1.Milk allergy in the neonatal intensive care unit: comparison between premature and full-term neonates
Yoshinori MORITA ; Hideo IWAKURA ; Harumi OHTSUKA ; Yoichi KOHNO ; Naoki SHIMOJO
Asia Pacific Allergy 2013;3(1):35-41
BACKGROUND: There have been several reports on neonates with milk allergy in a neonatal ward. This type of allergy is mostly categorized as a non-IgE-mediated food allergy. Although most cases of milk allergy occur in the first few months of life, the differences in clinical characteristics between premature and full-term neonates are still unclear. OBJECTIVE: This study aimed to clarify the differences in clinical characteristics of milk allergy between premature and full-term neonates. METHODS: We retrospectively evaluated 2,116 neonates admitted to the Department of Neonatology, Chiba Kaihin Municipal Hospital, between 2001 and 2007. RESULTS: We identified 24 neonates strongly suspected of having milk allergy because of symptoms, such as bloody stools, repeated vomiting, diminished sucking and abdominal distension, as well as objective laboratory findings of eosinophilia in stool cytology and/or positive results for a rectal milk challenge test. Twelve of these 24 neonates were premature (median gestational age, 31 ± 3 weeks; median birth weight, 1,656 ± 592 g) and the other 12 were full-term (median gestational age, 38 ± 1 weeks; median birth weight, 2,760 ± 560 g). There were no differences in symptoms and time to start of feeding between premature and full-term neonates, but there was a significant difference in the median postnatal age at onset (premature neonates: 23 days; vs. full-term neonates: 3.5 days; p < 0.01). CONCLUSION: All premature neonates developed a milk allergy after 32 weeks of corrected gestational age, suggesting that the development of milk allergy requires a certain degree of immunological maturation.
Age of Onset
;
Birth Weight
;
Eosinophilia
;
Food Hypersensitivity
;
Gestational Age
;
Hospitals, Municipal
;
Humans
;
Hypersensitivity
;
Infant, Newborn
;
Infant, Newborn
;
Intensive Care, Neonatal
;
Milk Hypersensitivity
;
Milk
;
Neonatology
;
Retrospective Studies
;
Vomiting
2.Interleukin-10 and interleukin-5 balance in patients with active asthma, those in remission, and healthy controls
Minako TOMIITA ; Eduardo CAMPOS-ALBERTO ; Masayuki SHIMA ; Masanobu NAMIKI ; Kazuo SUGIMOTO ; Hiroyuki KOJIMA ; Hiroko WATANABE ; Kunio SEKINE ; Toshiyuki NISHIMUTA ; Yoichi KOHNO ; Naoki SHIMOJO
Asia Pacific Allergy 2015;5(4):210-215
BACKGROUND: The immunological mechanisms of asthma remission remain unclear although several reports have suggested that balance between T helper (Th) 2 cytokines and regulatory cytokines is related. OBJECTIVE: To study the balance between interleukin (IL) 10 and IL-5 in asthma clinical remission. METHODS: We measured the numbers of IL-5 and IL-10 producing cells in peripheral blood mononuclear cells stimulated with mite antigen obtained from patients with active asthma (group A, n = 18), patients in clinical remission (group R, n = 15) and nonatopic healthy controls (group H, n = 14). RESULTS: The numbers of IL-5 producing cells in groups A and R were significantly higher than in group H. The number of IL-5 producing cells was lower in group R than in group A, although the difference was not statistically significant. The number of IL-10 producing cells was higher in group R than in group A, although again the difference was not statistically significant. There was a significant difference in the number of IL-10 producing cells between groups A and H but not between groups R and H. The ratio of the number of IL-10 to IL-5 producing cells was highest in group H followed by groups R and A, and the differences were statistically significant for each pair of groups. CONCLUSION: Our study suggests that the IL-10/IL-5 balance is related to clinical asthma. The balance differs between patients in clinical remission and healthy controls, suggesting that allergic inflammation may continue even after clinical asthma remission.
Asthma
;
Child
;
Cytokines
;
Humans
;
Inflammation
;
Interleukin-10
;
Interleukin-5
;
Interleukins
;
Mites
;
Prognosis
3.Immediate systemic allergic reaction in an infant to fish allergen ingested through breast milk
Takayasu ARIMA ; Eduardo CAMPOS-ALBERTO ; Hiraku FUNAKOSHI ; Yuzaburo INOUE ; Minako TOMIITA ; Yoichi KOHNO ; Naoki SHIMOJO
Asia Pacific Allergy 2016;6(4):257-259
This is a rare case report of systemic allergic reaction to fish allergen ingested through breast milk. Mother ate raw fish more than 3 times a week. Her consumption of fish was associated with urticaria and wheeze in an infant via breast-feeding. Fish-specific IgE antibodies were detected by skin prick test but not by in vitro IgE test. This case demonstrates that fish protein ingested by mother can cause an immediate systemic allergic reaction in offspring through breast-feeding. Although fish intake is generally recommended for prevention of allergy, one should be aware that frequent intake of fish by a lactating mother may sensitize the baby and induce an allergic reaction through breast-feeding.
Allergens
;
Antibodies
;
Breast
;
Fishes
;
Humans
;
Hypersensitivity
;
Immunoglobulin E
;
In Vitro Techniques
;
Infant
;
Milk, Human
;
Mothers
;
Skin
;
Urticaria
4.Pranlukast reduces asthma exacerbations during autumn especially in 1- to 5-year-old boys
Yoshinori MORITA ; Eduardo CAMPOS ALBERTO ; Shuichi SUZUKI ; Yoshinori SATO ; Akira HOSHIOKA ; Hiroki ABE ; Kimiyuki SAITO ; Toshikazu TSUBAKI ; Mana HARAKI ; Akiko SAWA ; Yoshio NAKAYAMA ; Hiroyuki KOJIMA ; Midori SHIGETA ; Fumiya YAMAIDE ; Yoichi KOHNO ; Naoki SHIMOJO
Asia Pacific Allergy 2017;7(1):10-18
BACKGROUND: Leukotriene receptor antagonists have been used to prevent virus-induced asthma exacerbations in autumn. Its efficacy, however, might differ with age and sex. OBJECTIVE: This study aimed to investigate whether pranlukast added to usual asthma therapy in Japanese children during autumn, season associated with the peak of asthma, reduces asthma exacerbations. It was also evaluated the effect of age and sex on pranlukast's efficacy. METHODS: A total of 121 asthmatic children aged 1 to 14 years were randomly assigned to receive regular pranlukast or not according to sex, and were divided in 2 age groups, 1–5 years and 6–14 years. The primary outcome was total asthma score calculated during 8 weeks by using a sticker calendar related to the days in which a child experienced a worsening of asthma symptoms. This open study lasted 60 days from September 15 to November 14, 2007. RESULTS: Significant differences in pranlukast efficacy were observed between sex and age groups. Boys aged 1 to 5 years had the lower total asthma score at 8 weeks (p = 0.002), and experienced fewer cold episodes (p = 0.007). There were no significant differences between pranlukast and control group in total asthma score at 8 weeks (p = 0.35), and in the days in which a child experienced a worsening of asthma symptoms (p = 0.67). CONCLUSION: There was a substantial benefit of adding pranlukast to usual therapy in asthmatic children, especially in boys aged 1 to 5 years, during autumn season.
Asian Continental Ancestry Group
;
Asthma
;
Child
;
Child, Preschool
;
Humans
;
Leukotriene Antagonists
;
Seasons